Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's disease.

Pre-print

First Author

Cruchaga, Carlos

PMID

Publication or Preprint Date

1/1/2024

Pre-print server

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.